TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.21), $0.05 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $21.28 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.